Login / Signup

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand.

Onanong WaleekhachonloetChulaporn LimwattananonThananan Rattanachotphanit
Published in: Therapeutic advances in drug safety (2019)
Coprescription of antipsychotics with interacting drugs that could increase the risk of QT prolongation was common in Thailand, and thioridazine, ziprasidone, and risperidone showed increasing trends. We urge the incorporation of a unified list of QT-prolonging antipsychotics and interacting drugs into a computerized drug interaction warning system, and existing national rational drug use campaigns should cover this important issue.
Keyphrases
  • drug induced
  • protein kinase
  • adverse drug
  • quality improvement
  • emergency department
  • clinical decision support